Page de couverture de AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast

Auteur(s): American Geriatrics Society
Écouter gratuitement

À propos de cet audio

This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org


© 2025 AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Épisodes
  • Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease
    Dec 17 2025

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Cindy Carlsson , Professor of Medicine Geriatrics at the University of Wisconsin School of Medicine and Public Health and staff physician at the Madison VA Hospital Geriatric Research, Education and Clinical Center (GRECC), Madison VA Memory Assessment Clinic, as they the role of fluid biomarkers in the Diagnosis of Alzheimer’s Disease.

    To view a transcript click here, then select the transcript tab.

    Voir plus Voir moins
    28 min
  • Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
    Oct 17 2025

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects.

    To view a transcript click here then select the transcript tab.

    Voir plus Voir moins
    26 min
  • The Role of Neuroimaging in Diagnosis of Alzheimer Disease
    Oct 17 2025

    Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of Neuroimaging in Diagnosis of Alzheimer Disease along with Jason Karlawish, MD, Professor of Medicine, medical ethics and health policy, and neurology at the University of Pennsylvania Perelman School of Medicine and Co-Associate Director of the Alzheimer’s Disease Research Center, and Co-Director of the Penn Memory Center.

    To view a transcript click here then select the transcript tab.

    Voir plus Voir moins
    17 min
Pas encore de commentaire